Biomarin Pharmaceutical (WBO:BMRN) Marketable Securities : €207 Mil (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Biomarin Pharmaceutical Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Biomarin Pharmaceutical's Marketable Securities for the quarter that ended in Mar. 2025 was €207 Mil.

Biomarin Pharmaceutical's annual Marketable Securities declined from Dec. 2022 (€535 Mil) to Dec. 2023 (€292 Mil) and declined from Dec. 2023 (€292 Mil) to Dec. 2024 (€186 Mil).

Biomarin Pharmaceutical Marketable Securities Historical Data

The historical data trend for Biomarin Pharmaceutical's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomarin Pharmaceutical Marketable Securities Chart

Biomarin Pharmaceutical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Marketable Securities

Get a 7-Day Free Trial

342.14

377.54

535.25

292.23

186.10

Biomarin Pharmaceutical Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Marketable Securities	Get a 7-Day Free Trial															275.62	234.30	229.75	186.10	206.77

Biomarin Pharmaceutical Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Biomarin Pharmaceutical (WBO:BMRN) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Biomarin Pharmaceutical Marketable Securities Related Terms

Thank you for viewing the detailed overview of Biomarin Pharmaceutical's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomarin Pharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomarin Pharmaceutical Inc (WBO:BMRN) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

BMRN:USA BMRN:Mexico 1BMRN:Italy 0HNC:UK BM8:Germany BM8:Germany B1MR34:Brazil

Address

770 Lindaro Street, San Rafael, CA, USA, 94901

Website

https://www.biomarin.com

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.